Investigation of cell signalings and therapeutic targets in ptprk-rspo3 fusion-positive colorectal cancer

HIGHLIGHTS

  • who: Jae Heon Jeong et al. from the INDIA have published the Article: Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer, in the Journal: PLOS ONE of 31/08/2022
  • what: The aim of this study is to identify key genes and cancer-related pathways specific for P:R fusion-positive CRC. In this study, statistical significance was determined as a p-value of 0.05 and false detection rate (FDR) as a q-value of 0.2 in over-representation analysis. In this study, drug candidates were identified . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?